Literature DB >> 10634713

Generic prescribing: time to regulate the market? Price rises are a blow to nascent primary care groups.

T Walley, P Burrill.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10634713      PMCID: PMC1128727          DOI: 10.1136/bmj.320.7228.131

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  1 in total

Review 1.  Patient pack prescribing and the provision of patient information leaflets.

Authors: 
Journal:  Drug Ther Bull       Date:  1995-11
  1 in total
  5 in total

1.  An integrated national pharmaceutical policy for the United Kingdom?

Authors:  T Walley; A Earl-Slater; A Haycox; A Bagust
Journal:  BMJ       Date:  2000-12-16

2.  The impact of a general practice group intervention on prescribing costs and patterns.

Authors:  Jane Walker; Nigel Mathers
Journal:  Br J Gen Pract       Date:  2002-03       Impact factor: 5.386

3.  The application of prescribing indicators to a primary care prescription database in Ireland.

Authors:  D Williams; K Bennett; J Feely
Journal:  Eur J Clin Pharmacol       Date:  2005-02-12       Impact factor: 2.953

4.  General practitioners' ranking of evidence-based prescribing quality indicators: a comparative study with a prescription database.

Authors:  Ifeanyi Okechukwu; Kathleen Bennett; John Feely
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

Review 5.  Differences in generic sertraline for children: real or artefact from cost containing to clinical quality of generics use.

Authors:  Bonati Maurizio; Maschi Silvia; Clavenna Antonio
Journal:  Eur J Clin Pharmacol       Date:  2006-11-07       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.